Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGelion Regulatory News (GELN)

Share Price Information for Gelion (GELN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.00
Bid: 17.00
Ask: 19.00
Change: 0.00 (0.00%)
Spread: 2.00 (11.765%)
Open: 18.00
High: 18.00
Low: 18.00
Prev. Close: 18.00
GELN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CEO Board Appointment and Grant of Options

12 Dec 2022 07:00

RNS Number : 3002J
Gelion PLC
12 December 2022
 

12 December 2022

Gelion plc

("Gelion" or the "Company")

 

CEO Board Appointment and Grant of Options

 

Further to the appointment of John Wood as CEO with effect from 21 November 2022, Gelion (AIM: GELN), the Anglo-Australian battery storage innovator, is pleased to announce his appointment to the Board with immediate effect, following the Company's AGM held on 9 December 2022 and completion of the required regulatory due diligence.

 

Grant of Options

 

In conjunction with Mr Wood's appointment to the Board, Mr Wood has been granted 2,704,000 options ("Options") to subscribe for new ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares"), in accordance with the terms of the Company's new Share Option Plan. The Options have an exercise price of 0.1 pence and will vest in three tranches as set out below, provided that on each vesting date Mr Wood is in continuous employment with Gelion. The Options expire, to the extent that they have not been exercised, on 12 December 2027.

 

- 1,622,400 Options will vest 12 months from the date of grant

- 540,800 Options will vest 24 months from the date of grant

- 540,800 Options will vest 36 months from the date of grant

 

All Options are subject to both malus and clawback provisions and good and bad leaver provisions. All unvested options will vest in certain corporate events such as a takeover of the company or a change of control. In these circumstances the Options would normally vest and become exercisable in full unless the Board decides that the Options will be pro-rated to take account of the date the corporate event took place during the normal vesting period.

 

Subsequent to this issue of Options, the Company has approximately 8.68 million Options in issue, representing 8.0 % of the Company's issued share capital.

 

Dr Steve Mahon, Chairman of Gelion, said: "I am delighted to welcome John to the Board. In the few short weeks since he joined as CEO, his wealth of commercial, battery and manufacturing experience is already coming to the fore. We look forward to the future under his leadership with a clear ambition to take Gelion to the next level of growth to deliver shareholder value."

 

 

CONTACTS

Gelion plc

Steve Mahon, Chairman

Amit Gupta, CFO

Thomas Maschmeyer, Founder and Principal Technology Advisor

 

 

via Alma PR

finnCap Ltd (Nominated Adviser and Sole Broker)

+44 207 220 0500

Corporate Finance

Christopher Raggett

Seamus Fricker

Fergus Sullivan

 

ECM

Barney Hayward

 

 

 

Alma PR (Financial PR Adviser)

Justine James

Josh Royston

Hannah Campbell

Will Ellis Hancock

 

+44 20 3405 0205

gelion@almapr.co.uk

 

 

 

Regulatory disclosures

 

The following information regarding John William Wood, aged 59, is disclosed under Schedule 2(g) of the AIM Rules for Companies:

 

Current directorships and/or partnerships:

Former directorships and/or partnerships (within the last five years):

 

Gelion Technologies Pty Limited

On The Jetty PTY Ltd

Out of the Woods Super PTY Ltd

Smart Storage PTY Ltd

Ecoult Holding Co.

 

As at 12 December 2022, John Wood beneficially holds 24,000 Ordinary Shares, representing 0.02% of the Company's issued share capital. In addition, he holds Options over 2,704,000 Ordinary Shares.

 

There are no further disclosures required under Schedule 2(g) of the AIM Rules for Companies.

 

The Notification of Dealing Form set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

John Wood

1. 

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

2. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Gelion plc

b)

LEI:

2138008NC7YL3MCUDR84

3. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Options over Ordinary Shares of 0.1p each

 

 

 

 

GB00BNBQZD59

b)

Nature of the transaction:

Grant of Options 

c)

Price(s) and volume(s):

Price(s)

Volume(s)

0.1p

2,704,000

 

 

d)

Aggregated information:

· Aggregated volume:

· Price:

N/A

 

e)

Date of the transaction:

12 December 2022

f)

Place of the transaction:

Outside of a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFAEDFEESEEE
12
Date   Source Headline
24th Apr 20248:30 amRNSMello Investor Presentation
4th Apr 20247:00 amRNSLi-S Cell High Energy Density Milestone Achieved
27th Mar 20247:00 amRNSInterim results to 31 December 2023
20th Mar 202410:09 amRNSNotice of Results and Investor Presentation
19th Mar 20247:00 amRNSLithium-Sulfur Battery development update
5th Feb 20247:00 amRNSSenior Leadership Team Appointments
29th Jan 20247:00 amRNSBlock Admission Return
16th Jan 202411:27 amRNSResult of General Meeting
22nd Dec 202310:41 amRNSExercise of Options, Director Shareholding & TVRs
21st Dec 202312:23 pmRNSResult of AGM
14th Dec 20234:15 pmRNSPosting of Annual Report and Notice of GM
13th Dec 20237:00 amRNSDirector/PDMR Shareholding - Grant of options
12th Dec 202312:00 pmRNSFinal results to 30 June 2023
1st Dec 20237:00 amRNSDirector/PDMR Dealings and Total Voting Rights
30th Nov 202312:40 pmRNSHolding(s) in Company
29th Nov 20237:00 amRNSNotice of Results and AGM
27th Nov 20234:54 pmRNSResult of GM and Total Voting Rights
23rd Nov 20237:01 amRNSNotice of Investor Presentation
23rd Nov 20237:00 amRNSResult of Retail Offer and Total Voting Rights
21st Nov 20237:00 amRNSGelion and Ionblox JDA signed
9th Nov 20231:00 pmRNSResult of Placing and Posting of Circular
9th Nov 20238:00 amRNSUK Retail Offer
9th Nov 20237:17 amRNSProposed Acquisition, Placing, Retail Offer and GM
11th Oct 20237:00 amRNSExpanded Li-S R&D Facility launched
15th Aug 20237:00 amRNSTrading update and two new agreements signed
27th Jul 20239:45 amRNSBlock Admission Return
6th Jul 20237:00 amRNSZinc battery solution and Lithium Sulfur update
5th Jul 20237:00 amRNSChange of Registered Office
1st Jun 202312:05 pmRNSDirector/PDMR Shareholding
31st May 202312:15 pmRNSDirector/PDMR Shareholding
25th May 20237:19 amRNSStrategic progress on Johnson Matthey IP acq
31st Mar 20237:00 amRNSTotal Voting Rights
28th Mar 20239:15 amRNSDirector/PDMR Shareholding
17th Mar 202310:45 amRNSDirector/PDMR Shareholding
16th Mar 20237:00 amRNSInterim results to 31 December 2022
13th Mar 20237:00 amRNSLithium Sulfur IP Acq + Innovation Challenge
9th Mar 20237:00 amRNSAcq. of Johnson Matthey’s battery IP portfolio
1st Mar 20238:17 amRNSTotal Voting Rights
24th Feb 20237:00 amRNSNotice of Results and Investor Presentation
27th Jan 20237:00 amRNSBlock Admission Return
16th Dec 202212:00 pmRNSDirector/PDMR Shareholding
12th Dec 20227:00 amRNSCEO Board Appointment and Grant of Options
9th Dec 202211:29 amRNSResult of AGM
6th Dec 20229:30 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSProof of performance additive viability
30th Nov 20229:50 amRNSDirector/PDMR Shareholding - Grant of options
24th Nov 202211:00 amRNSDirector/PDMR Shareholding
18th Nov 20229:00 amRNSDirector/PDMR Shareholding
15th Nov 20227:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20227:01 amRNSFinal results to 30 June 2022
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.